Financial Statements — HCM
Balance Sheet
(in billions USD)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 0.11 | 0.20 | 0.22 | 0.47 | 0.59 |
| Short-term Investments | 1.25 | 0.60 | 0.63 | 0.36 | 0.36 |
| Accounts Receivable | 0.15 | 0.16 | 0.13 | 0.08 | 0.06 |
| Inventory | 0.05 | 0.05 | 0.05 | 0.05 | 0.03 |
| Total Current Assets | 1.59 | 1.05 | 1.09 | 1.02 | 1.09 |
| Property, Plant & Equipment | 0.09 | 0.09 | 0.10 | 0.04 | 0.03 |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-current Assets* | 0.18 | 0.21 | 0.21 | 0.17 | 0.18 |
| Total Assets | 1.78 | 1.26 | 1.30 | 1.19 | 1.27 |
| Accounts Payable | 0.04 | 0.04 | 0.05 | 0.05 | 0.03 |
| Short-term Debt | 0.03 | 0.03 | -- | -- | -- |
| Total Current Liabilities | 0.34 | 0.37 | 0.34 | 0.32 | 0.25 |
| Long-term Debt | 0.09 | 0.08 | 0.04 | 0.00 | 0.03 |
| Total Non-current Liabilities* | 0.19 | 0.14 | 0.16 | 0.02 | 0.01 |
| Total Liabilities | 0.53 | 0.51 | 0.50 | 0.34 | 0.26 |
| Retained Earnings | (0.38) | (0.85) | (0.80) | (0.77) | (0.52) |
| Total Stockholder Equity | 1.23 | 0.74 | 0.78 | 0.80 | 0.98 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|---|
| Total Revenue | 277.68 | 305.68 | 532.87 | 202.05 | 157.36 |
| Cost of Revenue* | 167.58 | 180.14 | -- | -- | -- |
| Gross Profit | 110.10 | 125.55 | -- | -- | -- |
| Research & Development | 71.99 | 95.26 | 144.63 | 181.74 | 123.05 |
| Selling, General & Admin | 27.75 | 30.46 | 41.84 | 57.52 | 36.79 |
| Total Operating Expenses | 113.61 | 153.07 | -- | -- | -- |
| Operating Income | (3.51) | (27.52) | 111.65 | (196.75) | (143.73) |
| Interest Expense | -- | 1.48 | 0.22 | 0.40 | 0.24 |
| Pretax Income | 495.59 | (4.76) | 137.09 | (200.64) | (140.45) |
| Tax Provision | 63.16 | 2.89 | 2.73 | (4.21) | 1.86 |
| Net Income | 454.95 | 25.80 | 168.55 | (162.86) | (102.40) |
| Basic EPS | 0.53 | 0.03 | 0.20 | (0.19) | (0.14) |
| Diluted EPS | 0.52 | 0.03 | 0.19 | (0.19) | -- |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | (72.89) | (39.83) | 226.40 | (89.86) | (71.32) |
| Capital Expenditures | 9.27 | 10.11 | 24.36 | 15.75 | 8.91 |
| Free Cash Flow* | (82.16) | (49.94) | 202.04 | (105.61) | (80.23) |
| Investing Cash Flow | 17.59 | (5.43) | (315.96) | 259.71 | (155.89) |
| Financing Cash Flow | 9.32 | (32.56) | 5.83 | (74.64) | 578.33 |
* Derived from reported values